Bladder CancerConnect
Overview of Bladder Cancer
Terry Bradshaw's recent revelation may help highlight the cause, diagnosis, prevention and early detection of bladder cancer.
Treatment & Management of Bladder Cancer
Surgery, radiation, immunotherapy, & precision medicines and chemotherapy may all be used to treat bladder cancer
Can MRD Assessment with ctDNA in Muscle Invasive Bladder Cancer Improve Outcomes
Measurement of minimal residual disease in early stage bladder cancer personalizes treatment and improves outcomes.
Bladder Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Bladder Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Bladder Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Bladder Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Treatment of Stage 0 & I "Superficial" Bladder Cancer
Treatment of non-muscle invasive bladder cancers continues to improve with the use of immunotherpay.
Treatment of Stage II and III Bladder Cancer
The role of surgery, radiation and systemic treatment for state II and III bladder caner.
Treatment of Stage IV Bladder Cancer
Understand the role of surgery and systemic treatment with chemotherapy, immunotherapy and precision cancer medicines.
Muscle-Invasive Bladder Cancer: Imfinzi Perioperative Regimen Improves Outcomes
First immunotherapy regimen before and after surgery to demonstrate statistically significant and clinically meaningful overall survival improvement in this setting
Trodelvy for Advanced Bladder - Urothelial Cancers
Gilead will withdraw Trodelvy's indication for advanced urothelial cancer due to unmet primary endpoint in TROPiCS-04 trial
Understanding HER2 and its Treatment
HER2 positive cancers require treatment with specific targeted therapies of which there are several.
Treatment of Stage IV Bladder Cancer
Understand the role of surgery and systemic treatment with chemotherapy, immunotherapy and precision cancer medicines.
Side Effects of Treatment: "Chemo Brain"
Understand the signs and symptoms of "chemo brain" and what you can do to prevent and cope.
Healthy Diet, Happy Bladder
Everywhere we look in the media, we find claims that different diets can improve our quality of life.
Well-done Red Meat Increases Bladder Cancer Risk
Some individuals are more genetically susceptible to this risk.
Smoking Increases Bladder Cancer Risk
Cancer Epidemiology, Biomarkers and Prevention: "risk of bladder cancer increases with duration and amount of smoking."
Bladder Cancer News
Muscle-Invasive Bladder Cancer: Imfinzi Perioperative Regimen Improves Outcomes
First immunotherapy regimen before and after surgery to demonstrate statistically significant and clinically meaningful overall survival improvement in this setting
Trodelvy for Advanced Bladder - Urothelial Cancers
Gilead will withdraw Trodelvy's indication for advanced urothelial cancer due to unmet primary endpoint in TROPiCS-04 trial
Understanding HER2 and its Treatment
HER2 positive cancers require treatment with specific targeted therapies of which there are several.
New Gene Therapy for Bladder Cancer
A new FDA-approved gene therapy offers an alternative to complete bladder removal for patients with treatment-resistant non-muscle invasive bladder cancer.
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
On April 22, 2024, the Food and Drug Administration approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with Bacillus Calmette-Guérin (BCG) for adult patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.
Padcev (enfortumab vedotin) Treatment for Bladder Cancer
Padcev antibody drug conjugate combined with immunotherapy becomes standard of care for locally advanced bladder cancer.
Nadofaragene Firadenovec for High-risk Non–Muscle Invasive Bladder Cancer
The FDA has approved Adstiladrin (nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin–unresponsive non–muscle invasive bladder cancer (NMIBC) with carcinoma in situ with or without papillary tumors.
Advances in Genomic Testing-What you Need to Know
Genomic-Genetic Testing: What is FISH, PCR, ctDNA and Microarrays? How are they performed and what is their role in the management of cancer?
Immunotherapy Treatment of Cancer
Understand Personalized Medicine’s Quest to Unharness a Patient’s Own Immune System to Treat Their Cancer!
Opdivo Treatment of Bladder Cancer
The PD-1 Checkpoint Inhibitor Opdivo improves cancer free survival following surgical removal of bladder cancer
Ureteral Cancer and other Upper Tract Urothelial Cancers (UTUC)
Upper Tract Urothelial Cancers (UTUC) are uncommon but can be effectively treated.
Ask The Expert About Brain Tumors - Dr. Lakshmi Nayak of Dana Farber Cancer Inst
Dr. Lakshmi Nayak, MD, Dana-Farber Cancer Inst answers questions about brain cancer and its treatment.
Tumor Mutational Burden Identifies Cancer Responsive to Immunotherapy
FDA Approves Keytruda for TMB-High cancers. Understand the role of TMB testing in cancer treatment.
Questions Patients Should Ask Their Doctor When Determining Cancer Treatment
Get all the information you can as early as possible
Keytruda Improves Survival of Advanced Bladder Cancer
Keynote 45-Keytruda superior to chemotherapy for treatment of recurrent urothelial cancer.
Avelumab Immunotherapy Approved for Bladder Cancer
ASCO Update - Bavencio immunotherapy superior to improves bladder cancer treatment outcomes.
Treatment of Stage II and III Bladder Cancer
The role of surgery, radiation and systemic treatment for state II and III bladder caner.
Treatment of Stage 0 & I "Superficial" Bladder Cancer
Treatment of non-muscle invasive bladder cancers continues to improve with the use of immunotherpay.
Treatment of Stage IV Bladder Cancer
Understand the role of surgery and systemic treatment with chemotherapy, immunotherapy and precision cancer medicines.
Interleukin - 15 Agonist N-803 Effective in Resistant Superficial Bladder Cancer
FDA Grants N-803 Combo Breakthrough Therapy Status for Non-Muscle Invasive Bladder Cancer
Side Effects of Treatment: "Chemo Brain"
Understand the signs and symptoms of "chemo brain" and what you can do to prevent and cope.
Tecentriq Immunotherapy Provides Benefit in Advanced Bladder Cancer
The checkpoint inhibitor Tecentiq (atezolizumab) improves the outcomes of treatment for bladder cancer.
Vicinium Represents New Treatment Option for Non- Muscle Invasive Bladder Cancer
Vicinium promising for treatment of early stage and superficial bladder cancers.
Liquid Biopsy Detects Cancer Progression Much Earlier Than Imaging
What if a simple blood test could quickly determine when cancer treatment was ineffective and prevent its unnecessary use?
What You Should Know About Bladder Cancer
Dr. Michael O’Donnell, MD, Director of Urologic Oncology University of Iowa answers questions about bladder cancer.
Healthy Diet, Happy Bladder
Everywhere we look in the media, we find claims that different diets can improve our quality of life.
Bladder Cancer Newsletter
Stay Current With Bladder Cancer Treatment Advances & Connect with Others
Bone Cancer Newsletter
Stay Current With Bone Cancer Treatment Advances & Connect with Others
Cyramza® plus Taxotere® Promising in Advanced Bladder Cancer
Cyramza® plus Taxotere® Promising in Advanced Bladder Cancer
Immunotherapy Combination Shows Promise in Treatment of Bladder Cancer
IDO inhibitor epacadostat and the anti-PD-1 drug Keytruda (pembrolizumab) promising in bladder cancer.
Votrient® plus Taxol® Promising in Relapsed and Refractory Bladder Cancer
Study reports that ~ 60% of patients with advanced bladder cancer respond to Votrient/Taxol chemotherapy
Balversa - Erdafitinib FDA Approved for Treatment of Advanced Bladder Cancer
Doctors from MD Anderson report results of Balversa in advanced Urothelial cancer - Now FDA Approved
FDA Grants Fast Track Designation to GemRIS™ in Muscle Invasive Bladder Cancer
U.S. FDA Grants Fast Track Designation to GemRIS™ in Muscle Invasive Bladder Cancer
Taxotere® and Gemzar® is Effective for Treatment of Advanced Bladder Cancer
Taxotere® and Gemzar® is Effective for Treatment of Advanced Bladder Cancer
More Evidence that Diabetes Drugs Increase Risk of Bladder Cancer
More Evidence that Diabetes Drugs Increase Risk of Bladder Cancer
Well-done Red Meat Increases Bladder Cancer Risk
Some individuals are more genetically susceptible to this risk.
Chemo & Radiation May Prolong Survival Time for Persons with Bladder Cancer
Multi-Drug Chemo and Radiation Combo May Prolong Survival Time for Persons with Small-Cell Bladder Cancer
Radiation for Uterine Cancer May Increase Risk of Bladder Cancer
Radiation for Uterine Cancer May Increase Risk of Bladder Cancer
Study Evaluates Long-term Effects of Arsenic in Drinking Water on Bladder Cancer
Death rate from bladder cancer continues to rise 20 years after exposure to high levels of arsenic in drinking water.
A Large Study Helps Define Outcomes for Patients with Superficial Bladder Cancer
A Large Study Helps Define Outcomes for Patients with Superficial Bladder Cancer.
Cystoscopy Alone Is the Most Cost-effective Way to Monitor for of Bladder Cancer
Cystoscopy Alone Is the Most Cost-effective Way to Monitor for Recurrence of Bladder Cancer
Uncertain Whether P53 Predicts Bladder Cancer Prognosis
Uncertain Whether P53 Predicts Bladder Cancer Prognosis
Long-Term Survival with Aggressive Surgery in Advanced Bladder Cancer
Long-Term Survival with Aggressive Surgery in Advanced Bladder Cancer
Improved Outcomes with Higher Volumes for Radical Cystectomy
Improved Outcomes with Higher Volumes for Radical Cystectomy
Urine Test May Accurately Detect Bladder Cancer Recurrence
Urine Test May Accurately Detect Bladder Cancer Recurrence
Vitamins C, D, and E Don’t Reduce Risk of Bladder Cancer
Long-term use of vitamin C, vitamin D, or vitamin E does not appear to reduce the risk of bladder cancer.
Radical Cystectomy is Effective Therapy for Selected Patients Age 70 Years or Ol
Radical Cystectomy is Effective Therapy for Selected Patients Age 70 Years or Older with Invasive Bladder Cancer
High-Volume Hospitals Offer Better Outcomes for Radical Cystectomy
Study confirms experience of surgeon and hospital impacts treatment